Catalyst Wire Dossier Catalyst Wire Dossier

Gemesis

becaplermin · BioMimetic Therapeutics Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gemesis, covering 2009-11-20 to 2009-11-20. Get the full timeline:

Most recent: EMA Refused: Gemesis (becaplermin) — BioMimetic Therapeutics Ltd

See pricing